You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 8,632,802


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 8,632,802 protect, and when does it expire?

Patent 8,632,802 protects DAYTRANA and XELSTRYM and is included in two NDAs.

This patent has one patent family member in one country.

Summary for Patent: 8,632,802
Title:Device for transdermal administration of drugs including acrylic polymers
Abstract: A transdermal delivery system is provided where the drug delivery rates, onset and profiles of at least one active agent are controlled by selectively manipulating the monomeric make up of an acrylic-based polymer in the transdermal drug delivery system. The drug carrier composition may be comprised of (a) one or more acrylic-based polymers having one or more different monomers selected from the group consisting of hard and soft monomers; (b) one or more silicone-based polymers; and (c) one or more active agents where the device provides a desired solubility for the active agent and controls drug delivery rates, onset and profiles of at least one active agent.
Inventor(s): Kanios; David (Miami, FL)
Assignee: Noven Pharmaceuticals, Inc. (Miami, FL)
Application Number:13/229,007
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,632,802
Patent Claim Types:
see list of patent claims
Composition; Delivery; Use; Device;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 8,632,802

Introduction

United States Patent 8,632,802, titled "Device for transdermal administration of drugs including acrylic adhesive," is a patent that outlines a specific invention related to drug delivery systems. To analyze this patent, we need to delve into its various components, including the specification, claims, and the broader patent landscape.

Patent Structure

Document Number and Type

The patent number, US 8,632,802 B2, indicates that this is a U.S. patent with a previously published application, as denoted by the "B2" code[1].

Title and Abstract

The title of the invention is "Device for transdermal administration of drugs including acrylic adhesive," which is limited to 500 characters or less. The abstract provides a brief, non-technical description of the invention, giving an overview of what the patent covers[1].

Specification

The specification is a detailed written description of the invention. It includes discussions of related prior art, descriptions of the drawings, how the invention solves a specific technical problem, and the preferred embodiment of the invention. This section must be detailed enough for anyone with ordinary skill in the same technical field to understand and replicate the invention[1].

Claims

Definition and Purpose

The claims section is crucial as it defines the scope of protection for the patent. These claims are the legal boundaries of the invention, similar to how a property deed defines physical boundaries of land. The patent must have at least one claim, but typically includes several or even hundreds of claims[1].

Example Claim

For Patent 8,632,802, the claims would outline the specific components and functionalities of the transdermal drug delivery device. For instance, a claim might include:

  • A device comprising a first layer with an acrylic adhesive.
  • A second layer containing the drug to be administered.
  • A backing layer to protect the adhesive and drug.
  • Specific dimensions and materials used in the construction of the device.

Each claim would be numbered and would start with phrases like “I claim” or “What is claimed”[1].

Drawings and Figures

The drawings section contains black and white illustrations that provide technical details of the invention. These drawings are essential for understanding the physical structure and operation of the device, including any specific features or components mentioned in the claims[1].

Field of Search and Prior Art

The field of search section lists the classifications consulted by the patent examiner during the prior art search. This helps in understanding the broader context and related technologies that were considered when evaluating the novelty and non-obviousness of the invention. The references section cites U.S. and foreign patent documents and other publications that were considered as related prior art by the inventor and the patent examiner[1].

Applicants, Inventors, and Assignees

The patent lists the applicant, inventors, and assignees. The applicant is the person, company, or organization that filed the application. The inventors are those who created the invention, and the assignee is the owner of the patent at the time it was issued. This information is crucial for understanding the ownership and rights associated with the patent[1].

Patent Attorney or Agent

The patent also lists the patent attorney, agent, or firm that was hired by the inventor to prosecute the application. This professional played a key role in navigating the patent application process[1].

Patent Landscape

Related Patents and Publications

To understand the patent landscape, one must look at related patents and publications. Tools like the Patent Public Search, Global Dossier, and Common Citation Document (CCD) can be used to find prior art and related applications from participating IP offices. These resources help in identifying similar inventions and understanding how this patent fits into the broader field of transdermal drug delivery systems[4].

Economic and Statistical Analysis

The USPTO's Patent Claims Research Dataset can provide insights into the scope and trends of patent claims over time. This dataset includes detailed information on claims from U.S. patents granted between 1976 and 2014 and U.S. patent applications published between 2001 and 2014. It can help in analyzing the patent's scope and its position within the industry[3].

Legal and Policy Considerations

Small Claims Patent Court

The concept of a small claims patent court, as studied by the Administrative Conference of the United States (ACUS), could impact how patents like 8,632,802 are enforced and disputed. Such a court would aim to provide a more streamlined and cost-effective process for resolving patent disputes, which could affect the strategy and costs associated with defending or challenging this patent[2].

Key Takeaways

  • Detailed Specification: The patent includes a detailed specification that describes the invention, prior art, and preferred embodiments.
  • Claims: The claims define the legal boundaries of the invention and are crucial for understanding what is protected.
  • Drawings and Figures: The drawings provide technical details of the invention.
  • Field of Search and Prior Art: Understanding the classifications and prior art helps in evaluating the novelty and non-obviousness of the invention.
  • Ownership and Rights: The patent lists the applicants, inventors, and assignees, which is important for understanding ownership and rights.
  • Patent Landscape: Tools like Patent Public Search and Global Dossier help in identifying related patents and understanding the broader patent landscape.
  • Legal Considerations: The potential for a small claims patent court could impact how patent disputes are resolved.

FAQs

What is the purpose of the claims section in a patent?

The claims section defines the scope of protection for the patent, outlining what is legally protected and what constitutes infringement.

How do drawings contribute to the understanding of a patent?

Drawings provide technical details and illustrations of the invention, helping to clarify the physical structure and operation of the device.

What is the significance of the field of search in a patent?

The field of search indicates the classifications consulted by the patent examiner, helping to understand the broader context and related technologies considered during the evaluation of the invention.

How can one find related patents and publications?

Tools such as the Patent Public Search, Global Dossier, and Common Citation Document (CCD) can be used to find related patents and publications.

What is the role of a patent attorney or agent in the patent process?

A patent attorney or agent is hired by the inventor to navigate the patent application process, ensuring that the application is properly prepared and prosecuted.

Sources

  1. Guides.library.queensu.ca: How to Read a U.S. Patent - Patents and Designs - Research Guides.
  2. ACUS.gov: U.S. Patent Small Claims Court.
  3. USPTO.gov: Patent Claims Research Dataset.
  4. USPTO.gov: Search for patents - USPTO.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,632,802

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Noven Pharms Inc DAYTRANA methylphenidate FILM, EXTENDED RELEASE;TRANSDERMAL 021514-001 Apr 6, 2006 AB RX Yes No 8,632,802 ⤷  Subscribe Y ⤷  Subscribe
Noven Pharms Inc DAYTRANA methylphenidate FILM, EXTENDED RELEASE;TRANSDERMAL 021514-002 Apr 6, 2006 AB RX Yes No 8,632,802 ⤷  Subscribe Y ⤷  Subscribe
Noven Pharms Inc DAYTRANA methylphenidate FILM, EXTENDED RELEASE;TRANSDERMAL 021514-003 Apr 6, 2006 AB RX Yes No 8,632,802 ⤷  Subscribe Y ⤷  Subscribe
Noven Pharms Inc DAYTRANA methylphenidate FILM, EXTENDED RELEASE;TRANSDERMAL 021514-004 Apr 6, 2006 AB RX Yes Yes 8,632,802 ⤷  Subscribe Y ⤷  Subscribe
Noven Pharms Inc XELSTRYM dextroamphetamine SYSTEM;TRANSDERMAL 215401-001 Mar 22, 2022 RX Yes No 8,632,802 ⤷  Subscribe Y ⤷  Subscribe
Noven Pharms Inc XELSTRYM dextroamphetamine SYSTEM;TRANSDERMAL 215401-002 Mar 22, 2022 RX Yes No 8,632,802 ⤷  Subscribe Y ⤷  Subscribe
Noven Pharms Inc XELSTRYM dextroamphetamine SYSTEM;TRANSDERMAL 215401-003 Mar 22, 2022 RX Yes No 8,632,802 ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 8,632,802

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
World Intellectual Property Organization (WIPO) 2006041911 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.